Establishment of primary human epithelial ovarian cancer cells and their application to cytotoxicity assessment
Background: Ovarian carcinomas are highly metastatic tumors and the most lethal gynecological malignancies in the world. Treatment of human epithelial ovarian cancer (hEOC) is based on the combination of surgery and chemotherapy. The acquisition of resistance is a major obstacle to the clinical use...
Main Authors: | Chun-Kai Wang, Cheng-Kuo Lin, Li-Chun Huang, Ssu-Jen Chou, Chi-Kang Lin, Cheng-Chang Chang |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2019-01-01
|
Series: | Journal of Medical Sciences |
Subjects: | |
Online Access: | http://www.jmedscindmc.com/article.asp?issn=1011-4564;year=2019;volume=39;issue=6;spage=262;epage=266;aulast=Wang |
Similar Items
-
Novel application of pluronic lecithin organogels (PLOs) for local delivery of synergistic combination of docetaxel and cisplatin to improve therapeutic efficacy against ovarian cancer
by: Chia-En Chang, et al.
Published: (2018-01-01) -
Histopathological Efficacy of Docetaxel Versus Paclitaxel As First Line Chemotherapy for Epithelial Ovarian Carcinoma
by: Tayyup Şimşek, et al.
Published: (2008-12-01) -
Mitochondrial transplantation: Effects on chemotherapy in prostate and ovarian cancer cells in vitro and in vivo
by: Aybuke Celik, et al.
Published: (2023-05-01) -
Deregulation of Exo70 Facilitates Innate and Acquired Cisplatin Resistance in Epithelial Ovarian Cancer by Promoting Cisplatin Efflux
by: Yujie Zhao, et al.
Published: (2021-07-01) -
Early responses of the STAT3 pathway to platinum drugs are associated with cisplatin resistance in epithelial ovarian cancer
by: W.J. Sheng, et al.
Published: (2013-08-01)